Skin autofluorescence predicts new cardiovascular disease and mortality in people with type 2 diabetes.
Henderikus E BoersmaRobert P van WaateringeMelanie M van der KlauwReindert GraaffAndrew D PatersonAndries J SmitBruce H R WolffenbuttelPublished in: BMC endocrine disorders (2021)
Measuring SAF can assist in prediction of incident cardiovascular disease and mortality in individuals with T2D. SAF showed a stronger association with future CVD events and mortality than cholesterol or blood pressure levels.